Currently, information regarding Scopus Biopharma Inc.'s stock performance today is not available in the provided context.
What is Scopus Biopharma Inc. developing?
Scopus Biopharma Inc. is focused on developing a pipeline of novel immunotherapies for various cancers. Their lead product candidate, SCO-101, is an oral small molecule that targets the tumor microenvironment. They are also investigating SCO-303, an anti-VEGF/anti-VEGFR2 antibody [1].
What are the latest clinical trial updates for SCO-101?
SCO-101 is undergoing Phase 1 clinical trials in combination with checkpoint inhibitors like pembrolizumab for unresectable metastatic melanoma and non-small cell lung cancer. Early data from these trials are being assessed [1].
When is scopus biopharma inc. expected to release earnings?
Information on Scopus Biopharma Inc.'s upcoming earnings release schedule is not provided.
What is the mechanism of action for SCO-101?
SCO-101 is designed to disrupt the tumor microenvironment by enhancing the body's immune response against cancer cells. It aims to overcome resistance to existing immunotherapies [1].
What is the therapeutic potential of SCO-303?
SCO-303 is an antibody designed to inhibit vascular endothelial growth factor (VEGF) and its receptor (VEGFR2). This dual inhibition aims to reduce tumor angiogenesis and proliferation, potentially impacting cancer growth and spread [1].
Where can I find scopus biopharma inc. stock data?
To find real-time and historical stock data for Scopus Biopharma Inc., you would typically consult financial news websites, stock market tracking platforms, or brokerage accounts. Specific data points like today's stock price are not present in the provided information.
What is Scopus Biopharma Inc.'s strategy for cancer immunotherapy?
Scopus Biopharma Inc.'s strategy centers on developing novel immunotherapies that can work alone or in combination with existing treatments. Their approach leverages the manipulation of the tumor microenvironment to boost anti-cancer immunity [1].
Sources:
[1] https://www.scopusbiopharma.com/